Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
This is a clear earnings release disclosing AgEagle's financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of $2.7 million, gross margin of 50.6%, and cash position of $15.9 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing reports sequential revenue growth (nearly doubled from Q1) and provides forward guidance for the second half of 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
The 8-K discloses Nakamoto Inc.'s financial results for the second quarter ended June 30, 2026, via a press release dated August 13, 2026 filed under Item 2.02 (Results of Operations and Financial Condition). The filing reports total operating revenue of $35.9 million, an operating loss of $149.1 million (driven primarily by $105.2 million in goodwill impairment and $48.7 million in mark-to-market losses on digital assets), and a net loss of $133.0 million. This is a standard quarterly earnings release disclosure, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
The 8-K discloses Sidus Space's financial results for Q2 2026 ended June 30, 2026, via Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) provides detailed quarterly revenue ($583K), net loss ($4.8M), cash position ($166.5M), and operational highlights including completion of launch qualification milestones and a $100M capital raise. This is a standard earnings release disclosure material to investors assessing the company's financial condition and operational progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
The 8-K discloses Canton Strategic Holdings' financial and operating results for Q2 2026 under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports the company's first operating revenue ($1.5M for Q2), including $1.3M from locking-as-a-service and $191K from validator operations, along with consolidated financial statements showing a net loss of $19.3M and significant digital asset holdings. This is a standard quarterly earnings release material to investors assessing the company's operational performance and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-08-14
The 8-K discloses financial results for Q2 2026 via Item 2.02 and an attached press release (Exhibit 99.1). While the press release emphasizes the completed Cataneo acquisition ($19.5M), the primary 8-K Item filed is 2.02 (Results of Operations and Financial Condition), and the filing announces the Form 10-Q submission. However, the acquisition is equally prominent and material. The earnings_release classification is chosen because Item 2.02 is the stated disclosure vehicle, though ma_activity would also be defensible given the acquisition's prominence and materiality.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-14
Item 2.02
The filing discloses Upland Software's financial results for the second quarter ended June 30, 2026, issued via press release on August 14, 2026. The press release presents quarterly revenue ($49.1 million), net loss ($35.3 million GAAP), Adjusted EBITDA ($12.8 million), and forward guidance for Q3 and full-year 2026. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
This is a clear earnings release for the fiscal quarter ended June 30, 2026. The Item 2.02 disclosure announces quarterly financial results via a press release (Exhibit 99.1) that includes detailed financial statements, revenue figures ($2.5 million for Q2 2026), operating results (net loss of $30.3 million), and balance sheet data. The filing explicitly states "Solana Company Reports Second Quarter 2026 Financial Results" and provides comprehensive financial highlights and operational metrics typical of a quarterly earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-14
Item 2.02
LanzaTech issued a press release on August 14, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing revenue of $9.0 million, operating expenses of $11.7 million, net income of $184.3 million (driven by a non-cash unrealized gain on SGLT investment), and Adjusted EBITDA of $(7.6) million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 8.01
The filing discloses Cycurion's Q2 2026 financial results via a press release dated August 14, 2026, furnished as Exhibit 99.1. The press release reports revenue of $3.8 million (beating consensus of $3.62 million), EPS of $(0.41) (beating consensus of $(0.56)), and a nearly five-fold improvement in gross margin to 29.1%. The document includes detailed quarterly consolidated results of operations and non-GAAP reconciliations, which are hallmarks of an earnings release disclosure under Item 8.01 (Other Events).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
This is a quarterly earnings release for Vistagen's fiscal year 2027 first quarter ended June 30, 2026, disclosing financial results including revenue of $1.5 million, R&D expense of $10.9 million, G&A expense of $3.9 million, and a net loss of $13.0 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes condensed consolidated balance sheets and statements of operations, and the company provides forward-looking guidance on cash runway and expense trends.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-14
EX-99.1
This is a press release announcing APWC's financial results for Q2 2026 (ended June 30, 2026), disclosing quarterly revenue of $136.6 million (up 8% year-over-year), operating profit of $3.4 million (up 36% year-over-year), and EPS of $0.01. The document includes detailed consolidated income statements, balance sheets, and cash flow statements for the quarter and six-month period, along with segment revenue breakdowns and management commentary on operational performance. This is a classic earnings release event material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-14
Item 2.02
The filing discloses financial results for Q2 2026 via a press release announcing the Company's regained SEC reporting status and filing of its Form 10-Q. The press release reports specific financial metrics including total current assets of $8.4 million, marketable securities of $4.5 million, notes receivable of $3.4 million, and a swing to positive working capital of $1.1 million. This constitutes a periodic earnings/financial results disclosure typical of Item 2.02, though the materiality here is heightened by the company's return to SEC compliance after a multi-year gap.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
This Item 2.02 disclosure announces Vulcan Infrastructure and Power Inc.'s financial and operating results for Q2 2026 ended June 30, 2026, furnished via press release (Exhibit 99.1). The filing reports quarterly revenue of $3.4 million, net loss of $9.9 million, and EBITDA loss of $8.5 million, along with operational highlights including a $39.4 million strategic investment and debt management activities. This is a standard quarterly earnings release material to investors assessing the company's financial performance and strategic position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
TOMI Environmental Solutions issued a press release on August 14, 2026 disclosing financial results for Q2 2026 ended June 30, 2026. The filing explicitly states "On August 14, 2026, TOMI Environmental Solutions, Inc. issued a press release regarding its financial results for the second quarter ended June 30, 2026" and the press release is attached as Exhibit 99.1. The disclosure includes detailed quarterly revenue ($2.25M, up 118% YoY), gross profit, operating loss, net loss per share, and full-year 2026 guidance of $12M revenue. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-14
Item 2.02
Smith-Midland issued a press release on August 14, 2026 announcing its second quarter 2026 financial results, including revenue of $23.4 million, gross profit of $5.4 million, operating income of $2.0 million, and net income of $1.4 million ($0.26 per diluted share). The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. Item 2.02 discloses financial results including revenue of $5.8 million, operating loss of $3.4 million, and net income of $27.0 million (driven by $39.2 million in non-recurring litigation settlement gains). The press release attached as Exhibit 99.1 presents quarterly financial results with detailed commentary on operations, expenses, and cash position, which is the hallmark of an earnings disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
Data Storage Corporation issued a press release on August 14, 2026 disclosing financial results for the quarter ended June 30, 2026, including condensed consolidated balance sheets, statements of operations, and cash flows. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes quarterly revenue ($358,530), gross profit, operating loss, and per-share metrics, making this a material earnings disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-14
Item 2.02
This is a press release announcing financial results for the three and six months ended June 30, 2026, furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition). The release discloses Q2 2026 revenue, gross profit, net income, and Adjusted EBITDA, making it a standard earnings release. While the filing also contains material disclosures regarding going-concern doubt, Nasdaq delisting risk, and liquidity concerns, the primary event disclosed in Item 2.02 is the quarterly financial results announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-14
Item 2.02
Bally's Corporation published a press release on August 14, 2026, reporting financial results for the second quarter ended June 30, 2026. The disclosure includes consolidated revenue of $792.2 million (up 20.5% year-over-year), segment-level revenue and EBITDAR metrics, and management commentary on operational performance. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the canonical form of earnings disclosure in 8-K filings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
Beneficient issued a press release on August 14, 2026 announcing financial results for the first quarter ended June 30, 2026, disclosing consolidated revenues, operating income/loss, segment performance, balance sheet metrics, and business highlights. This is a standard quarterly earnings release furnished under Item 2.02 with detailed financial tables and operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-14
Item 2.02
MediaCo disclosed its second quarter 2026 financial results via press release on August 14, 2026, reporting net revenues of $33.969 million (9% growth) and a net loss of $8.613 million for Q2, with year-to-date revenues of $65.355 million and net loss of $17.981 million. This is a standard quarterly earnings release filed under Item 2.02, materially affecting investor assessment of the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-14
Item 2.02
FiEE, Inc. issued a press release on August 14, 2026 announcing unaudited financial results for the fiscal quarter and six months ended June 30, 2026, including revenue of $6.9 million for H1 2026 (up 15,298% YoY), gross profit of $5.4 million, net income of $2.5 million (a turnaround from prior-year loss), and diluted EPS of $0.17.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-14
EX-99.5
This is a press release announcing first quarter fiscal 2027 financial results for Helus Pharma (Cybin Inc.), including cash position ($166.4 million), net loss ($47.8 million), and operating expenses ($37.5 million) for the quarter ended June 30, 2026. The document explicitly states "Helus Pharma Reports First Quarter Fiscal 2027 Financial Results" and includes financial highlights typical of an earnings release. While the release also discusses business milestones (CEO appointment, clinical trial progress), the primary disclosure is the quarterly financial results, making this an earnings_release rather than a periodic report.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-14
Item 2.02
Nuvve disclosed Q2 2026 financial results for the quarter ended June 30, 2026, reporting total revenues of $1.23 million (up 268.4% year-over-year), gross profit margins of 2.6%, and a net loss of $7.3 million, with $0.5 million in cash on hand as of the quarter end.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-14
Item 2.02
Teamshares reported Q2 2026 financial results ended June 30, 2026, with revenue of $148.7 million (20% YoY increase), net income of $9.5 million (vs. loss in prior year), and Adjusted EBITDA of $9.6 million (166% increase). The company reaffirmed its 2026 outlook and held a conference call to discuss results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release disclosing quarterly and year-to-date financial results for Dillard's, Inc. The press release announces net income of $97.7 million ($6.25 per share) for the 13 weeks ended August 1, 2026, and $348.2 million ($22.30 per share) for the 26 weeks ended August 1, 2026, compared to prior-year periods. The filing includes condensed consolidated financial statements and is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Creative Media & Community Trust Corporation disclosed its financial results for the second quarter ended June 30, 2026 via press release dated August 14, 2026, reporting a net loss of $(11.0) million, FFO of $(3.5) million, Core FFO of $(3.4) million, and detailed segment performance metrics for office, hotel, and multifamily properties.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
EX-99.1
This exhibit is a presentation for an "Earnings Conference Call 2Q26" disclosing Suzano's second-quarter 2026 financial results. It contains detailed operational and financial metrics including Adjusted EBITDA (R$4.7 billion), Adjusted Free Cash Flow (R$3.3 billion), net debt (US$6.9 billion), leverage ratios, sales volumes, pricing data, and segment performance for pulp and paper/packaging businesses. The document explicitly states it covers 2Q26 results with comparisons to prior periods, making it a material earnings disclosure that would affect investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
This is a press release disclosing Arcos Dorados' second quarter 2026 financial results, dated August 13, 2026. The document reports total revenues of $1.3 billion (up 14.3% YoY), Adjusted EBITDA of $126.8 million (up 15.2% YoY), and net income of $45.0 million ($0.22 per share), all described as record or near-record results for a second quarter. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
This is a standard earnings release disclosing Q2 2026 financial results for Intellicheck, Inc., filed under Item 2.02 (Results of Operations and Financial Condition). The press release reports revenue of $5.9 million (up 16% YoY), net income of $0.7 million, and adjusted EBITDA of $1.1 million, along with complete financial statements and management commentary. The disclosure is material as it provides quarterly results that would affect a reasonable investor's assessment of the company's financial performance and operational trends.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-13
EX-99.1
This exhibit is a press release announcing China Automotive Systems' unaudited financial results for the first six months ended June 30, 2026. It discloses record net sales of $412.5 million (up 20.1% YoY), net income attributable to parent company shareholders of $29.3 million (up 98.8% YoY), and diluted EPS of $0.97 (up 98.0% YoY), along with detailed financial statements and management commentary. This is a classic earnings release for an interim period, material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
EX-99.2
This exhibit is a press release announcing Evotec's Q2 and H1 2026 financial results, including revenues of €143.5m (Q2) and €300.1m (H1), adjusted EBITDA of -€20.8m and -€42.7m respectively, and a significantly revised full-year 2026 outlook (€570-€610m revenues vs. prior €700-€780m; -€70 to -€105m EBITDA vs. prior €0-€40m). The material downward revision in guidance and negative EBITDA trajectory would affect a reasonable investor's assessment of the company's financial performance and recovery trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
EX-99.1
This exhibit is a press release announcing ProQR's second quarter 2026 operating and financial results, including Q2 net loss of €8.7 million, cash position of €117.1 million, and key clinical milestones (positive AX-0810 Phase 1 target engagement data establishing first clinical validation of the Axiomer platform). The document contains unaudited interim condensed consolidated financial statements (balance sheet, P&L, changes in equity) and is clearly a results announcement for the period ended June 30, 2026, making it an earnings_release rather than a periodic_quarterly report.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
EX-99.2
This exhibit is a press release announcing ProQR's second quarter 2026 operating and financial results, including Q2 net loss of €8.7 million, cash position of €117.1 million, and key clinical milestones (AX-0810 Phase 1 target engagement data, AX-0811 CTA submission, financing of $59.2 million). The document explicitly states "ProQR Therapeutics N.V. (Nasdaq: PRQR)...today reported its financial and operating results for the second quarter ended June 30, 2026" and includes unaudited interim condensed consolidated financial statements (balance sheet, income statement, changes in equity). This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Zenas BioPharma reported Q2 2026 financial results for the quarter ended June 30, 2026, disclosing revenue of $1.0 million, R&D expenses of $62.9 million, G&A expenses of $15.7 million, net loss of $111.5 million, and cash position of $673.9 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
This is a standard earnings release disclosing quarterly financial results for Q2 2026 (quarter ended June 30, 2026). The filing includes condensed consolidated balance sheets, statements of operations with net loss of $6.9 million for the quarter, and per-share metrics. The press release was issued on August 13, 2026, and furnished as Exhibit 99.1, which is the typical format for Item 2.02 earnings disclosures. While the release also includes corporate updates on clinical trial progress, the primary disclosure is the financial results for the period.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
Yesway issued a press release on August 13, 2026 announcing financial results for the second quarter ended June 30, 2026, disclosing net income of $29.7 million (up from $24.2 million), Adjusted EBITDA of $70.9 million (up 35% year-over-year), and increased full-year 2026 Adjusted EBITDA guidance to $235–$245 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, materially affecting investor assessment of the registrant's operating performance and financial condition.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-13
EX-99.3
This exhibit is a press release announcing NervGen's second quarter 2026 financial results, including cash position (C$86.8 million), R&D and G&A expenses, and net loss (C$29.2 million). The document explicitly states "NervGen Reports Second Quarter 2026 Financial Results" and provides detailed quarterly financial metrics. While the release also includes business updates (Phase 3 RESTORE study progress, leadership appointments), the primary disclosure is the quarterly earnings announcement, which is material to investors assessing the company's financial condition and runway.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
EX-99.1
This exhibit is a press release announcing Xunlei's unaudited financial results for the second quarter ended June 30, 2026. It discloses total revenues of US$102.7 million (up 38.9% YoY), gross profit of US$57.3 million, and a net loss from continuing operations of US$218.5 million (compared to net income of US$726.4 million in Q2 2025). The dramatic swing from profitability to loss, driven primarily by fair value changes in the company's long-term investment in Arashi Vision Inc., is material to investors' assessment of the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
MeiraGTx issued a press release on August 13, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 2026 financial and operational results including cash position ($143.2 million), service revenue ($11.9 million), related-party service revenue ($104.9 million), and license revenue ($204.6 million). This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, meeting the definition of earnings_release.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-13
EX-99.1
This is a press release announcing GDS Holdings' unaudited financial results for the second quarter ended June 30, 2026. The document discloses quarterly net revenue (RMB3,088.0 million, up 6.5% Y-o-Y), net income (RMB837.6 million vs. prior-year loss of RMB70.6 million), adjusted EBITDA, and operating metrics. The company also provides updated full-year 2026 guidance. This is a discrete earnings announcement, not a periodic financial report, and is material to investors assessing the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Dogwood Therapeutics issued a press release on August 13, 2026 announcing financial results for the second quarter ended June 30, 2026, including R&D expenses of $3.2 million, G&A expenses of $1.6 million, a $9.2 million IPR&D impairment charge, and a net loss of $11.5 million ($0.34 per share). The filing explicitly states this is Item 2.02 disclosure with the press release incorporated as Exhibit 99.1, which is the standard format for quarterly earnings releases. The disclosure includes both operational highlights (clinical trial progress, FDA approvals, scientific advisory board appointment) and detailed financial statements, making it material to investors' assessment of the company's financial condition and progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
zSpace issued a press release on August 13, 2026 announcing financial results for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $5.4 million, net income of $0.3 million (versus a net loss of $6.1 million in Q2 2025), and gross margin expansion to 56% from 43%. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, and the results are material to investors as they show a significant swing to profitability and margin improvement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026). The Item 2.02 disclosure announces financial results including collections of $300.9 million, net income of $41.3 million, and EPS of $0.67, with the full press release furnished as Exhibit 99.1. The filing includes consolidated balance sheets and statements of operations, which are standard components of quarterly earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-13
Item 2.02
MultiSensor AI Holdings issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $1.7 million (19% growth), software revenue of $0.7 million (85% growth), and net loss of $2.5 million (26% improvement year-over-year), with condensed consolidated financial statements and management commentary provided.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
ProMIS Neurosciences issued a press release on August 13, 2026, reporting financial results for the quarter ended June 30, 2026, including a net loss of $11.7 million, cash position of $53.4 million, and cash runway through 2027. The filing explicitly states under Item 2.02 that the Company "issued a press release...reporting its financial condition and financial results as of and for the quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1 and incorporated by reference. The exhibit contains condensed consolidated balance sheets and statements of operations for the periods ended June 30, 2026 and 2025, which are standard quarterly financial results disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026, furnished as a press release exhibit (EX-99.1) under Item 2.02. The filing discloses financial results including revenue ($0), operating expenses ($42.9M for Q2), and net loss ($40.7M or $0.70 per share), along with cash position ($237.9M) and financial outlook. While the press release also includes material regulatory and clinical updates regarding Deramiocel's FDA review and HOPE-3 results, the Item 2.02 classification centers on the financial results disclosure itself.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
AudioEye issued a press release on August 13, 2026, reporting financial results for the fiscal quarter ended June 30, 2026 (Q2 2026). The disclosure includes quarterly revenue ($10.7M, up 9% YoY), ARR ($42.3M, up 11% YoY), adjusted EBITDA ($3.0M, a record), adjusted EPS ($0.23), and full-year 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-13
Item 2.02
KULR Technology Group disclosed Q2 2026 quarterly earnings results showing significant financial deterioration: revenue declined 43% year-over-year to $2.08M, gross margin was negative 31%, operating loss increased 19% to $11.2M, and net loss was $22.0M or $0.47 per share compared to prior-year net income of $0.22 per share, with material non-cash fair value losses on bitcoin holdings contributing to the results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The filing discloses quarterly financial results including total revenue of $46.5 million (up 12.1% YoY), net income of $0.3 million (vs. prior-year loss of $0.7 million), and key operational metrics such as AuM growth of 13.4% to $31.6 billion. The press release is furnished as Exhibit 99.1 and contains consolidated balance sheet and statement of operations, making this a material earnings disclosure under Item 2.02.
View raw filing on EDGAR →